Skip to main content
. 2016 Dec 1;6(2):143–148. doi: 10.5005/jp-journals-10018-1187

Table 3: Referral indication for OGD and diagnostic yield according to ASGE guideline criteria

ASGE indication of referral   Overall, % (n = 1,019)   Relevant lesion, %   LR+   LR–  
• Appropriate indication                          
 1. Upper abdominal symptoms persistent despite therapy   11.8   66.7   1.91   0.92  
 2. Upper abdominal symptoms associated with symptoms and signs suggesting serious organic disease or in patients aged >45 years   7.9   91.3   9.96   0.87  
 3. Esophageal reflux symptoms persistent or recurrent despite therapy   2.9   76.7   3.14   0.96  
 4. Portal hypertension evaluation   0.5   100   10.51   0.99  
 5. Active or recent GI bleeding   12.9   53.4   1.09   0.98  
 6. Suspected chronic bleeding   4.9   56   1.21   0.99  
 7. Dysphagia or odynophagia   7.3   52.7   1.06   0.99  
 8. GI assessment in other medical disorders   2.0   55   1.16   0.99  
 9. Persistent vomiting of unknown cause   3.9   80   3.82   0.95  
 10. Sclerotherapy or variceal bleeding   0.5   100   10.51   0.99  
 11. Histologic assessment of a neoplasia detected radiologically   1.0   60   1.43   0.99  
 12. Others   2.6   46.2   0.81   1  
 13. Total   58   65   1.77   0.45  
• Not appropriate indications                          
 1. Symptoms considered functional   17   38.7   0.64   1.32  
 2. Surveillance of healed benign lesions   22   25.9   0.33   1.33  
 3. Others   3.0   38.7   0.64   1.01  
 4. Total   42   32   0.45   1.77  

GI: Gastrointestinal